You are here
New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016
Primary tabs
New data from ten late-breaking abstracts is released at ECCMID 2016 – the annual meeting of the European Society of Clinical Microbiology and Infectious Disease (ESCMID). At the congress, a dedicated session will examine recently released research across the full spectrum of infectious diseases both from a clinical and laboratory perspective.
Researchers presented recent data on a number of diagnostic tools to rapidly identify pathogens and therapies promising to treat challenging infections. The abstracts presented dealt with topics including meningitis, pulmonary tuberculosis, Zika and human papilloma virus.
Abstracts described the long-term clinical implications of Zika virus exposure, demonstrating that it can produce a number of neurological and ocular complications. Additionally, scientists found that the drug bedaquiline used to treat multidrug-resistant tuberculosis was a safe and effective long-term treatment option in selected cases. Finally, urgent changes were recommended to the technology and temperature management during open-heart surgery to prevent the growth of M. chimaera bacteria.
Recent Comments